Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche's Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS

pharmafileNovember 20, 2018

Tag: Ocrevus , MS , ECTRIMS

PharmaSources Customer Service